首页> 外文会议>Conference on single-use technologies II: bridging polymer science to biotechnology applications >Development and large scale manufacturing of exosome-based therapeutics
【24h】

Development and large scale manufacturing of exosome-based therapeutics

机译:基于外泌体的疗法的开发和大规模生产

获取原文

摘要

1. Many "-somes" in the literature 2. Exosomes, endosomes, ectosomes. oncosomes, dectosomes, connectosomes, gohstosomes, vexosomes, FedExosomes,... 3. No standard definition translatable into characterization methods 4. Typical exosome attributes Size (40-200 nm) a. Canonical surface proteins (CD9, CD47, CD63, CD81, etc.) b. Relevant functional assays (uptake, biodistribution, etc.) c. However, above attributes overlap with other Extracellular Vesicles.
机译:1.文献中许多“-体” 2.外体,内体,外体。脂质体,蜕膜体,连接体,真丝囊泡,角膜囊泡,FedExosomes,...。3.没有标准定义可转化为表征方法。4.典型的囊泡属性大小(40-200 nm)a。典型的表面蛋白(CD9,CD47,CD63,CD81等)b。相关功能测定(摄取,生物分布等)c。但是,以上属性与其他细胞外囊泡重叠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号